Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Flexion Therapeutics Inc (NASDAQ:FLXN)

18.44
Delayed Data
As of Jan 20
 -0.06 / -0.32%
Today’s Change
7.56
Today|||52-Week Range
23.57
-3.05%
Year-to-Date
No recent news for Flexion Therapeutics Inc.

Today’s Trading

Previous close18.50
Today’s open18.53
Day’s range18.16 - 18.81
Volume127,483
Average volume (3 months)349,687
Market cap$575.8M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-9.14%
Earnings growth (this year)-26.98%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.84

Competitors

 Today’s
change
Today’s
% change
RVNCRevance Therapeutics...-0.20-0.98%
ACHNAchillion Pharmaceut...-0.03-0.73%
VNDAVanda Pharmaceutical...-0.35-2.57%
KERXKeryx Biopharmaceuti...-0.21-3.72%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.71
Annual revenue (last year)$0.00
Annual profit (last year)-$46.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael D. Clayman
Chief Financial Officer
Frederick W. Driscoll
Corporate headquarters
Burlington, Massachusetts

Forecasts


Search for Jobs